Adam Scott Levy, CFO, Chief Business Officer and Secretary at Mineralys Therapeutics, Inc. (MLYS), bought 6,250 shares at $16.00 ($100K) on 2023-02-14, disclosed to the SEC on 2023-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |